Implementation of IVS3 for Upper Limb Motor Recovery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWeill Medical College of Cornell University
About this trial
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.
Eligibility criteria
Qualifiers
Age ≥ 18 years old
English speaking
History of ischemic or hemorrhagic stroke ≥ 6 months prior to study enrolment
FMA-UE: 20 < x < 50 (moderate impairments)
Disqualifiers
Spasticity or increased tone with MAS ≥3 in the upper extremity
Unable to communicate effectively or provide informed consent
Significant visual impairments
Concurrent occupational therapy being received outside of the study
Trial design
Treatments tested in this trial
- Intensive Visual Stimulation Device
Treatment groups
25 Participants
are divided into 2 treatment groupsLocations
1Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-210610065, New YorkNew York, United States
Sponsors and collaborators
Weill Medical College of Cornell University
Lead sponsor
Dessintey Inc.
Collaborator
Source ClinicalTrials.gov